Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 4,071 | 2,818 | 6,172 | 3,526 | 2,142 |
| Cost of Goods | 1,781 | 1,897 | 1,872 | 2,968 | -1,727 |
| Gross Profit | 2,290 | 921 | 4,300 | 558 | 3,869 |
| Operating Expenses | 16,572 | 18,639 | 15,520 | 16,175 | 15,273 |
| Operating Income | -13,501 | -16,821 | -10,348 | -14,649 | -12,131 |
| Other Income | -353 | -588 | -436 | -514 | -406 |
| Pre-tax Income | -13,854 | -17,409 | -10,784 | -15,163 | -12,537 |
| Income Tax | N/A | -7,714 | -13,768 | -996 | -823 |
| Net Income Continuous | -13,854 | -9,695 | 2,984 | -14,167 | -11,714 |
| Net Income Discontinuous | N/A | -65 | 34,883 | 2,978 | 1,769 |
| Net Income | $-13,854 | $-9,760 | $37,867 | $-11,189 | $-9,945 |
| EPS Basic Total Ops | -388.70 | -265.30 | 1,092.07 | -327.00 | -296.15 |
| EPS Basic Continuous Ops | -388.09 | -271.47 | 86.38 | -413.38 | -345.51 |
| EPS Basic Discontinuous Ops | N/A | 6.17 | 1,005.69 | 86.38 | 49.36 |
| EPS Diluted Total Ops | -388.70 | -252.96 | 1,079.73 | -327.00 | -296.15 |
| EPS Diluted Continuous Ops | -388.09 | -271.47 | 86.38 | -413.38 | -345.51 |
| EPS Diluted Discontinuous Ops | N/A | 18.51 | 993.35 | 86.38 | 49.36 |
| EBITDA(a) | $-12,914 | $-16,685 | $-9,073 | $-13,774 | $-11,290 |